GBLB Stock Analysis: Groep Brussel Lambert | BR
Asset Management | BR, Belgium | Market Cap: 9.187m EUR | 12M Return: 8.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.82M
Rev. Trend: -50.9%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Groupe Bruxelles Lambert (GBL) is a Belgian multi-sector holding company that invests in a diversified portfolio of industrial, consumer goods, and business service companies across Belgium, Europe, North America, and other international markets. The group operates through six reporting segments: Holding, Imerys (minerals-based specialty materials), Canyon, Affidea, Sanoptis, and GBL Capital together with Sienna Investment Managers, combining direct operating assets with asset management activities.
Founded in 1902 and headquartered in Brussels, GBL follows a long-established holding company model in which value is generated primarily through the active management of strategic equity stakes in operating subsidiaries and portfolio companies, supplemented by management and performance fees from its investment management arm. As a multi-sector holdings company within the Financials sector, GBLs earnings are typically driven by dividend income from investees, fair value changes on its investment portfolio, and the operating performance of consolidated subsidiaries, rather than from any single product line or geographic market.
- Imerys margins soften on weaker European industrial demand
- Affidea and Sanoptis drive healthcare segment NAV growth
- Buyback program and portfolio disposals narrow discount to NAV
| Net Income: -603.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.44 > 1.0 |
| NWC/Revenue: 25.87% < 20% (prev 46.01%; Δ -20.14% < -1%) |
| CFO/TA 0.03 > 3% & CFO 747.1m > Net Income -603.6m |
| Net Debt (4.09b) to EBITDA (359.8m): 11.36 < 3 |
| Current Ratio: 3.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (129.2m) vs 12m ago 0.12% < -2% |
| Gross Margin: 54.02% > 18% (prev 45.10%; Δ 8.92% > 0.5%) |
| Asset Turnover: 25.75% > 50% (prev 22.32%; Δ 3.43% > 0%) |
| Interest Coverage Ratio: -0.72 > 6 (EBIT TTM -228.9m / Interest Expense TTM 316.8m) |
| A: 0.07 (Total Current Assets 2.43b - Total Current Liabilities 679.4m) / Total Assets 25.1b |
| B: 0.28 (Retained Earnings 6.95b / Total Assets 25.1b) |
| C: -0.01 (EBIT TTM -228.9m / Avg Total Assets 26.3b) |
| D: 1.14 (Book Value of Equity 13.4b / Total Liabilities 11.7b) |
| Altman-Z'' = 2.51 = A |
As of July 28, 2026, the stock is trading at EUR 77.75 with a total of 79,861 shares traded. Over the past week, the price has changed by +0.84%, over one month by -2.14%, over three months by +4.16% and over the past year by +8.38%.
Current recommended Stop Loss: 76.30 (which is 1.9% or 1.5 ATR below the current price).
Groep Brussel Lambert has no consensus analysts rating.
P/E Forward = 25.7069
P/S = 1.4214
P/B = 0.7937
P/EG = 0.5212
Revenue TTM = 6.76b EUR
EBIT TTM = -228.9m EUR
EBITDA TTM = 359.8m EUR
Long Term Debt = 6.78b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 780.6m EUR (from shortTermDebt, last fiscal year)
Debt = 8.21b EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 764.1m
Net Debt = 4.09b EUR (calculated: Debt 8.21b - CCE 4.13b)
Enterprise Value = 13.3b EUR (9.19b + Debt 8.21b - CCE 4.13b)
Interest Coverage Ratio = -0.72 (Ebit TTM -228.9m / Interest Expense TTM 316.8m)
EV/FCF = 192.4x (Enterprise Value 13.3b / FCF TTM 69.0m)
FCF Yield = 0.52% (FCF TTM 69.0m / Enterprise Value 13.3b)
FCF Margin = 1.02% (FCF TTM 69.0m / Revenue TTM 6.76b)
Net Margin = -8.93% (Net Income TTM -603.6m / Revenue TTM 6.76b)
Gross Margin = 54.02% ((Revenue TTM 6.76b - Cost of Revenue TTM 3.11b) / Revenue TTM)
Gross Margin QoQ = 72.41% (prev 47.47%)
Tobins Q-Ratio = 0.53 (Enterprise Value 13.3b / Total Assets 25.1b)
Interest Expense / Debt = 3.86% (Interest Expense 316.8m / Debt 8.21b)
Taxrate = 21.63% (18.0m / 83.2m)
NOPAT = -179.4m (EBIT -228.9m * (1 - 21.63%)) [loss with tax shield]
Current Ratio = 3.58 (Total Current Assets 2.43b / Total Current Liabilities 679.4m)
Debt / Equity = 0.61 (Debt 8.21b / totalStockholderEquity, last quarter 13.4b)
Debt / EBITDA = 11.36 (Net Debt 4.09b / EBITDA 359.8m)
Debt / FCF = 59.22 (Net Debt 4.09b / FCF TTM 69.0m)
Total Stockholder Equity = 12.9b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.30% (Net Income -603.6m / Total Assets 25.1b)
RoE = -4.68% (Net Income TTM -603.6m / Total Stockholder Equity 12.9b)
RoCE = -1.16% (EBIT -228.9m / Capital Employed (Equity 12.9b + L.T.Debt 6.78b))
RoIC = -0.72% (negative operating profit) (NOPAT -179.4m / Invested Capital 24.8b)
WACC = 5.21% (E(9.19b)/V(17.4b) * Re(7.17%) + D(8.21b)/V(17.4b) * Rd(3.86%) * (1-Tc(0.22)))
Discount Rate = 7.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -53.83 | Cagr: -4.80%
[DCF] Terminal Value 73.10% ; FCFF base≈340.2m ; Y1≈298.3m ; Y5≈241.0m
[DCF] Fair Price = N/A (negative equity: EV 3.87b - Net Debt 4.09b = -217.4m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -50.93 | Revenue CAGR: -6.39% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.35 | Chg30d=-11.65% | Revisions=-25% | GrowthEPS=-17.8% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=2.37 | Chg30d=-12.87% | Revisions=-25% | GrowthEPS=+0.9% | GrowthRev=+3.0%